Clinical Trials Browser

Phase 2 × tomivosertib × Gastrointestinal × Clear all

NCT03258398 2019-07-18

A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT03318562 2019-07-18

A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC

Phase 2 Terminated

BreastGastrointestinal

Carcinoma, Hepatocellular, Triple Negative Breast Neoplasms